Skip to Content

  • Search

View Additional Section Content

Clinical Protocol MB102073: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)

Clinical Trial Categories

  • Diabetes
  • Hypertension
Annette Fudala, RMA, CRC at 215-355-9770


  • Feasterville Family Health Care Center N/A
    1665 Bustleton Pike
    Feasterville, PA 19053

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details